申请人:The University of British Columbia
公开号:US20020045621A1
公开(公告)日:2002-04-18
Methods and compositions, useful in the treatment of amyloidosis and conditions and diseases associated therewith, such as Alzheimer's Disease (AD). These methods involve administering to a subject a pharmaceutical composition including one or more agents which modulate APP catabolism and amyloid deposition. Accordingly, the methods and compositions are useful for inhibiting amyloidosis in disorders in which amyloid deposition occurs. The methods are based, at least in part, on modulating catabolism of APP in APP-containing cells through the use of a mobile ionophore, such as carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone, which does not substantially alter the viability of those cells.
用于治疗淀粉样变性以及与之相关的病症和疾病,如阿尔茨海默病(AD)的方法和组合物。这些方法包括向受试者施用药物组合物,其中包括一种或多种调节 APP 分解和淀粉样蛋白沉积的制剂。因此,这些方法和组合物可用于抑制淀粉样蛋白沉积疾病中的淀粉样蛋白沉积症。这些方法至少部分基于通过使用移动离子诱导体,如羰基氰化对(三氟甲氧基)苯基腙,调节含APP细胞中APP的分解代谢,该诱导体不会大幅改变这些细胞的活力。